AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: OPDIVO (Bristol Myers Squibb) (opdivo.com)
OPDIVO delivers high-substance clinical information but fails forensically by trapping its proof in a closed-loop system without technical authority markers. It is a scientifically legitimate site that suffers from an ‘authority vacuum’ caused by the complete lack of schema and external verification links. The BS is low, but the ‘Trust Theatre’ is high due to the unverified review counts.
Immediately implement Organization and Product schema to link the website to the official Bristol Myers Squibb corporate identity. Replace generic ‘Patient Stories’ headers with specific trial identifiers (e.g., ‘Checkmate-67T results’) to increase information density. Add direct outbound links to PubMed or ClinicalTrials.gov for every efficacy claim made on the subcutaneous-injection page. Map the ‘Medication Guide’ and ‘Side effects tracker’ to specific technical documentation to move beyond the template fingerprint.
The site exhibits high substance in its body text, specifically citing a clinical trial of 495 people with kidney cancer and exact administration times (3-5 minutes vs 30 minutes). However, the information density is diluted by significant concept repetition, with the 3-5 minute injection claim appearing as a primary value driver on all 4 analyzed pages. Fluff headings such as ‘Every second counts’ and ‘Explore another way you may receive treatment’ occupy prime real estate but lack the technical specificity found in the clinical sub-sections.
AI treats every internal link as a semantic statement — not a navigation hint. Validate your entity level link signals and confirm whether your anchors reinforce meaning or generate noise.
Alignment across the site is exceptionally high, with zero drift between the homepage signal and sub-page substance. The homepage H3 ‘Explore another way you may receive treatment’ is directly supported by the technical breakdown on the subcutaneous-injection page regarding the hyaluronidase enzyme. Positioning for Advanced Kidney Cancer and Melanoma remains consistent, targeting the same patient demographic without conflicting service descriptions.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
A significant trust theatre flag is triggered by the presence of a 9-10 review count across all pages with zero accompanying proof links (proof_links_count: 0). While ‘Katy’s Story’ is presented as a patient testimonial, the lack of external validation links to peer-reviewed studies or clinical trial registries within the forensic data creates a ‘walled garden’ of proof. The site relies on internal trust theatre patterns like ‘FDA-approved’ and ‘clinically proven’ without providing an outbound path to the raw evidence.
The ratio of evidence to assertions is high relative to other industries, but low for biotech. There are approximately 2-3 specific clinical markers (495 people, 3-5 minutes, hyaluronidase mention) against dozens of vague assertions regarding ‘support journeys’ and ‘helpful resources’. The reliance on internal FAQs rather than external documentation reduces the overall proof density score.
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The site follows a standard pharmaceutical template fingerprint, utilizing boilerplate sections like ‘Patient Resources’, ‘Cost information and financial help’, and ‘Patient stories’. Cliché density is moderate, utilizing industry-standard phrases like ‘advancing human health’ and ‘life-changing therapies’ in meta descriptions. However, the value proposition is saved from being a commodity by the highly specific technical differentiator of the subcutaneous delivery method.
Forensic analysis reveals a total absence of structured data (schema_json: null) across the entire site, which is a major technical authority gap for a multi-billion dollar biotech brand. While the site references a real patient (‘Katy’), there is no Person schema or sameAs links to verify her identity or the authenticity of the testimonial. The technical implementation lags behind the brand’s positioning as a leader in medical science.
The central performance claim that OPDIVO Qvantig showed ‘similar results and side effects’ to IV infusions is bolstered by clinical trial mentions, yet it lacks direct forensic proof paths in the data. The marketing tone shifts from emotional (‘Every second counts’) to clinical, but the site never bridges the gap with a direct link to the specific peer-reviewed publication or ClinicalTrials.gov registration number (e.g., NCT number) in the text analyzed.
Medical Devices, Pharma & Biotech BS: OPDIVO (Bristol Myers Squibb) (opdivo.com)
The content perfectly aligns with the Pharma & Biotech sector, focusing on immunotherapy (nivolumab) and subcutaneous delivery systems (hyaluronidase-nvhy). The presence of heavy regulatory disclaimers, indication lists, and clinical trial citations (495 people study) confirms its status as a high-compliance pharmaceutical product site.
AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.
“The score of 36 is driven primarily by technical authority gaps (Step 5) and the trust theatre flag (Step 3). The high review count without verifiable proof links is the single largest contributor to the BS score. Despite these technical failures, the semantic coherence and unique value proposition keep the score firmly in the 'Low BS' category compared to typical marketing sites.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 31, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at OPDIVO (Bristol Myers Squibb) to view the most current version of their content and see directly what the company offers.